Gastroplasty
Endoscopic sleeve gastroplasty ‘effective alternative’ for MASH, obesity management
Endoscopic sleeve gastroplasty with lifestyle intervention was more effective than lifestyle changes alone in achieving weight loss and histological improvement in patients with metabolic dysfunction-associated steatohepatitis and obesity.
Top 25 US insurers fail to provide coverage for intragastric balloon, endoscopic sleeve
PHILADELPHIA — None of the top 25 insurers in the United States offer explicit policy coverage for primary or revisional endoscopic bariatric therapies, according to data presented at the ACG Annual Scientific Meeting.
Weight loss surgery more ‘cost saving’ over long term vs. semaglutide for class II obesity
Endoscopic sleeve gastroplasty was more cost-effective and sustained greater weight loss over 5 years compared with semaglutide for patients with class II obesity, according to data published in JAMA Network Open.
Endoscopic sleeve gastroplasty scoring system predicts reintervention with 74% probability
A novel scoring system could aid clinicians by predicting the risk for 30-day reintervention among patients who underwent endoscopic sleeve gastroplasty, according to data published in Gastrointestinal Endoscopy.
Endoscopic sleeve gastroplasty an effective option for patients with NASH, obesity
Endoscopic sleeve gastroplasty was more effective for weight loss than lifestyle modification alone in patients with nonalcoholic steatohepatitis and obesity, according to a speaker at EASL Congress.
Endoscopic sleeve gastroplasty induces, maintains weight loss in mild, moderate obesity
Endoscopic sleeve gastroplasty safely induced and maintained weight loss and improved metabolic comorbidities in patients with class 1 and class 2 obesity, according to research published in The Lancet.
Bariatric endoscopy opens ‘leadership role’ to GIs for obesity management
Endoluminal therapy for weight loss delivered by flexible endoscopy has had appeal for nearly 20 years. The continued growth in the global prevalence of obesity makes the need for new and better treatment options more critical than ever.
Bariatric endoscopy ‘bridges the gap’ on obesity management spectrum
The obesity epidemic is one of today’s most blatantly visible — yet actively neglected — public health concerns, affecting more than 1 billion people globally, according to WHO.
FDA grants de novo clearance for endoscopic sleeve gastroplasty, bariatric revision devices
The FDA has granted de novo authorization for Apollo Endosurgery to market its Apollo ESG and Apollo REVISE endoscopic systems for the treatment of patients with obesity, according to a company press release.